Kuan Arthur 4
4 · CG Oncology, Inc. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
Kuan Arthur
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-04-15+527,660→ 527,660 totalExercise: $20.11Exp: 2035-04-14→ Common Stock (527,660 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date.